Investing
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Once combined, the company will operate as HeartFlow Group and trade on the NYSE under symbol HFLO.
The Israeli company now has a total of $9 million in venture funding.
This brings the company's total raise to $140 million.
The company’s production studio has created over 2,000 original videos that span a variety of conditions and procedures.
The company is planning on using the new funds to expand its library and build more capabilities.
Halfway through this year, digital health has received $14.7 billion in funding – already more than 2020’s full-year amount of $14.6 billion.
The Boston and Tel Aviv-based company includes a predictive analytics tool which helps intervene in a person's aging trajectory.
Amedisys will now have access to Contessa health's hospital-at-home and skill nursing facility services.
This new funding brings the company's total funding pot to $135 million.